Clomiphene citrate and Tamoxifen are the two cornerstone SERMs used in post-cycle therapy (PCT), yet they differ noticeably in how they interact with estrogen receptors and how they restart the hypothalamic-pituitary-testicular axis (HPTA). Their distinct mechanisms shape the speed, stability, and tolerability of hormonal recovery after steroid use.